Skip to main content
Close
What is TYMLOS?

TYMLOS is a prescription medicine used to:

  • Treat osteoporosis in postmenopausal women who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well. TYMLOS can decrease the chance of having a fracture of the spine and other bones in postmenopausal women with thinning and weakening bones (osteoporosis).
  • Increase bone density in men with osteoporosis who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well.

It is not known if TYMLOS is safe and effective for children and young adults 18 years and younger. TYMLOS should not be used in children and young adults whose bones are still growing.

Not actual patient

TYMLOS is proven
to add to the bone Rebuild new bone—add bone density,
create momentum, and push back
on osteoporosis

TYMLOS is specifically designed to activate
your body’s natural bone-rebuilding process.

TYMLOS mimics the way your body naturally regulates the addition and removal of bone. It activates bone
formation throughout, adding to the bone. Watch TYMLOS in action.

Are you ready to add bone today?

TYMLOS is taken daily for up to 2 years, using an injection pen. TYMLOS is an FDA-approved treatment for men and postmenopausal women with osteoporosis.

TYMLOS is a proven treatment option for people who:

Are at high risk for fracture

OR

Have already had a fracture

OR

Have tried other osteoporosis treatments without success

TYMLOS showed significant increases in
bone mineral densities (BMD) compared to placebo.

There was no evidence of
differences in the effects
of TYMLOS on BMD
across different:
Results in
Women
Results in
Men

For women, at 18 months TYMLOS was proven to significantly reduce
the risk of fracture while increasing BMD

Reduced risk in the spine by

0.6% of women taking TYMLOS had a spinal fracture vs 4.2% of women taking placebo

Reduced risk in non-spinal areas by

2.7% of women taking TYMLOS had a non-spinal fracture vs 4.7% of women taking placebo

The mean change in BMD from the beginning to the end of the study for TYMLOS vs placebo:

From the beginning to the end of the study for Tymlos vs placebo, in women, the mean change in BMD of the spine was 9.2% compared to 0.5%

Spine:
9.2% vs 0.5%

From the beginning to the end of the study for Tymlos vs placebo, in women, the mean change in BMD of the hip was 3.4% compared to -0.1%

Hip:
3.4% vs –0.1%

From the beginning to the end of the study for Tymlos vs placebo, in women, the mean change in BMD of the neck of the femur was 2.9% compared to -0.4%

Neck of
the femur:
2.9% vs –0.4%

Study Design

An international clinical study including more than 2,460 postmenopausal women evaluated the safety and how effective TYMLOS was at treating osteoporosis by reducing the risk for fracture in postmenopausal women. Women taking TYMLOS were compared with women taking a placebo (an injection that did not contain any medicine) for 18 months.

For men, after 12 months of TYMLOS, BMD was increased at the
spine, hip, and neck of the femur compared to men taking placebo

The mean change in BMD from the beginning to the end of the study for TYMLOS vs placebo:

From the beginning to the end of the study for Tymlos vs placebo, in men, the mean change in BMD of the spine was 8.5% compared to 1.2%

Spine:
8.5% vs 1.2%

From the beginning to the end of the study for Tymlos vs placebo, in men, the mean change in BMD of the hip was 2.1% compared to <0.1%

Hip:
2.1% vs <0.1%

From the beginning to the end of the study for Tymlos vs placebo, in men, the mean change in BMD of the neck of the femur was 3.0% compared to 0.2%

Neck of
the femur:
3.0% vs 0.2%

Study Design

An international clinical study including more than 228 men evaluated the safety and how effective TYMLOS was at increasing BMD in men with osteoporosis. Men taking TYMLOS were compared with men taking a placebo (an injection that did not contain any medicine) for 12 months.

Ready to talk about TYMLOS with your doctor?

If you're at a high risk for fracture due to osteoporosis, we can help start the conversation

Download our guide (opens in a new tab)

Fit TYMLOS into your daily routine

Learn more about how to take TYMLOS

Looking to take
the next step with TYMLOS?

Get information about 1-on-1 support, request a starter kit, and stay in the loop with the latest TYMLOS updates

Sign up now

IMPORTANT SAFETY INFORMATION AND
INDICATIONS

OpenClose

IMPORTANT SAFETY INFORMATION AND INDICATIONS

What is the most important information I should know about TYMLOS?
TYMLOS may cause serious side effects including:

Possible bone cancer (osteosarcoma). During animal drug testing, TYMLOS caused some rats to develop a bone cancer called osteosarcoma. It is not known if people who take TYMLOS will have a higher chance of getting osteosarcoma.

  • Tell your healthcare provider right away if you have pain in your bones, pain in any areas of your body that does not go away, or any new or unusual lumps or swelling under your skin that is tender to touch.
Do not take TYMLOS:
  • if you had an allergic reaction to abaloparatide or any of the other ingredients in TYMLOS. The inactive ingredients in TYMLOS are phenol, sodium acetate trihydrate, acetic acid, and water for injection.
Before you take TYMLOS, tell your healthcare provider about all of your medical conditions, including if you:
  • have Paget’s disease of the bone or other bone disease.
  • have or have had any of the following: cancer in your bones; radiation therapy involving your bones; too much calcium in your blood; or an increase in your parathyroid hormone (hyperparathyroidism).
  • will have trouble injecting yourself with the TYMLOS pen and do not have someone who can help you.
  • are pregnant or plan to become pregnant, because TYMLOS is not for pregnant women, or if you are breastfeeding or plan to breastfeed. It is not known if TYMLOS passes into your breast milk; you should not take TYMLOS and breastfeed.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of TYMLOS?
TYMLOS can cause serious side effects including:
  • Decrease in blood pressure when you change positions. Some people may feel dizzy, have a faster heartbeat, or feel lightheaded soon after the TYMLOS injection is given. These symptoms generally go away within a few hours. Take your injection of TYMLOS in a place where you can sit or lie down right away if you get these symptoms. If your symptoms get worse or do not go away, stop taking TYMLOS and call your healthcare provider.
  • Increased blood calcium (hypercalcemia). TYMLOS can cause some people to have a higher blood calcium level than normal. Your healthcare provider may check your blood calcium before you start and during your treatment with TYMLOS. Tell your healthcare provider if you have nausea, vomiting, constipation, low energy, or muscle weakness. These may be signs there is too much calcium in your blood.
  • Increased urine calcium (hypercalciuria). TYMLOS can cause some people to have higher levels of calcium in their urine than normal. Increased calcium may also cause you to develop kidney stones (urolithiasis) in your kidneys, bladder, or urinary tract. Tell your healthcare provider right away if you get any symptoms of kidney stones which may include pain in your lower back or lower stomach area, pain when you urinate, or blood in your urine.
The most common side effects of TYMLOS in women with postmenopausal osteoporosis include:
  • dizziness, nausea, headache, fast heartbeat, feeling tired (fatigue), upper stomach pain, and spinning feeling (vertigo).
The most common side effects of TYMLOS in men with osteoporosis include:
  • redness at injection site, dizziness, joint pain, swelling at injection site, pain at injection site, bruising, abdominal bloating, diarrhea, nausea, abdominal pain, and bone pain.

These are not all the possible side effects of TYMLOS. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

How should I use TYMLOS?
  • Read the complete Instructions for Use (opens in a new tab) provided with your medicine.
  • If you take more TYMLOS than prescribed you may experience symptoms such as muscle weakness, low energy, headache, nausea, dizziness (especially when getting up after sitting for a while), and a faster heartbeat. Stop taking TYMLOS and call your healthcare provider right away.
  • You should not use TYMLOS for more than 2 years over your lifetime.
What is TYMLOS?

TYMLOS is a prescription medicine used to:

  • Treat osteoporosis in postmenopausal women who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well. TYMLOS can decrease the chance of having a fracture of the spine and other bones in postmenopausal women with thinning and weakening bones (osteoporosis).
  • Increase bone density in men with osteoporosis who are at high risk for bone fracture, or who cannot use another osteoporosis treatment or other osteoporosis treatments did not work well.

It is not known if TYMLOS is safe and effective for children and young adults 18 years and younger. TYMLOS should not be used in children and young adults whose bones are still growing.

Please read the full Prescribing Information (opens in a new tab), including Medication Guide (opens in a new tab).